The ROE as of November 2024 (TTM) for Bionano Genomics, Inc. (BNGO) is -215.83%

According to Bionano Genomics, Inc.’s latest financial reports and current stock price. The company's current ROE is -215.83%. This represents a change of 335.15% compared to the average of -49.60% of the last 4 quarters.

Bionano Genomics, Inc. (BNGO) Historical ROE (quarterly & annually)

How has BNGO ROE performed in the past?

The mean historical ROE of Bionano Genomics, Inc. over the last ten years is -165.76%. The current -215.83% ROE has changed 30.20% with respect to the historical average. Over the past ten years (40 quarters), BNGO's ROE was at its highest in in the June 2019 quarter at 569.94%. The ROE was at its lowest in in the December 2019 quarter at -218.63%.

Bionano Genomics, Inc. (BNGO) ROE by Quarter and Year

Discovering the peaks and valleys of Bionano Genomics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bionano Genomics, Inc. (BNGO) Average ROE

How has BNGO ROE performed in the past?

The current ROE of Bionano Genomics, Inc. (BNGO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bionano Genomics, Inc. (BNGO) ROE vs. Peers

How is BNGO’s ROE compared to its peers?

Bionano Genomics, Inc.’s ROE is less than Intuitive Surgical, Inc. (15.59%), greater than Innovative Eyewear, Inc. (-128.68%), greater than Stereotaxis, Inc. (-101.61%), greater than NEXGEL, Inc. (-69.99%), greater than Microbot Medical Inc. (-173.35%), less than STAAR Surgical Company (5.39%), greater than Envista Holdings Corporation (-37.24%), less than G Medical Innovations Holdings Ltd (208.58%), less than Becton, Dickinson and Company (5.51%), less than West Pharmaceutical Services, Inc. (18.35%), less than ResMed Inc. (23.22%), less than Wearable Health Solutions, Inc. (12.86%), less than BioLife Sciences Inc. (0%), less than Psykey, Inc. (671.52%), greater than Predictive Oncology Inc. (-200.05%), greater than Sharps Technology, Inc. (-100.70%), greater than GlucoTrack, Inc. (-513.94%), less than Meihua International Medical Technologies Co., Ltd. (6.27%),

Build a custom stock screener for Bionano Genomics, Inc. (BNGO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionano Genomics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bionano Genomics, Inc. (BNGO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bionano Genomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.